Maj J, Skuza G, Sowińska H, Nowak G. Pharmacological properties of EXP 561, a potential antidepressant drug. Journal of Neural Transmission. 1987, 70 (1–2): 81–97. PMID 2822850. S2CID 23469131. doi:10.1007/BF01252511.
Ross SB, Kelder D. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum. Acta Pharmacologica et Toxicologica. May 1979, 44 (5): 329–35. PMID 474143. doi:10.1111/j.1600-0773.1979.tb02339.x.
nih.gov
ncbi.nlm.nih.gov
Maj J, Skuza G, Sowińska H, Nowak G. Pharmacological properties of EXP 561, a potential antidepressant drug. Journal of Neural Transmission. 1987, 70 (1–2): 81–97. PMID 2822850. S2CID 23469131. doi:10.1007/BF01252511.
Lehmann HE, Ban TA, Debow SL. A clinical-pharmacological study with EXP 561. Current Therapeutic Research, Clinical and Experimental. June 1967, 9 (6): 306–8. PMID 4963065.
Gershon S, Hekimian LJ, Floyd A. Non-correlation of preclinical-clinical evaluation of a prosposed anti-depressant 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561). Arzneimittel-Forschung. February 1968, 18 (2): 243–5. PMID 5695389.
Ross SB, Kelder D. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum. Acta Pharmacologica et Toxicologica. May 1979, 44 (5): 329–35. PMID 474143. doi:10.1111/j.1600-0773.1979.tb02339.x.
semanticscholar.org
api.semanticscholar.org
Maj J, Skuza G, Sowińska H, Nowak G. Pharmacological properties of EXP 561, a potential antidepressant drug. Journal of Neural Transmission. 1987, 70 (1–2): 81–97. PMID 2822850. S2CID 23469131. doi:10.1007/BF01252511.